Table 2 Survival rate of NLR, PLR and HGB grouping
From: The prognostic value of routine preoperative blood parameters in muscle-invasive bladder cancer
Grouping | Years | Progression-free survival rate | Cancer-specific survival rate | Overall survival rate |
|---|---|---|---|---|
NLR < 2.42 | 1 | 80.0% | 88.4% | 87.3% |
2 | 73.5% | 78.8% | 77.9% | |
5 | 68.5% | 68.9% | 64.9% | |
NLR ≥ 2.42 | 1 | 70.6% | 73.2% | 70.6% |
2 | 64.9% | 66.5% | 64.2% | |
5 | 60.6% | 59.5% | 56.1% | |
PLR < 112 | 1 | 78.5% | 85.6% | 85.6% |
2 | 75.0% | 77.8% | 77.8% | |
5 | 68.8% | 69.8% | 66.9% | |
PLR ≥ 112 | 1 | 72.2% | 75.3% | 71.8% |
2 | 63.5% | 66.9% | 63.8% | |
5 | 60.6% | 58.0% | 53.9% | |
HGB < 125 | 1 | 64.5% | 72.7% | 70.9% |
2 | 54.6% | 59.7% | 58.2% | |
5 | 50.6% | 48.6% | 45.6% | |
HGB ≥ 125 | 1 | 84.7% | 87.4% | 85.6% |
2 | 82.5% | 84.1% | 82.3% | |
5 | 77.2% | 78.3% | 74.0% |